BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hargunani P, Tadge N, Ceruso M, Leitans J, Kazaks A, Tars K, Gratteri P, Supuran CT, Nocentini A, Toraskar MP. Aryl-4,5-dihydro-1H-pyrazole-1-carboxamide Derivatives Bearing a Sulfonamide Moiety Show Single-digit Nanomolar-to-Subnanomolar Inhibition Constants against the Tumor-associated Human Carbonic Anhydrases IX and XII. Int J Mol Sci 2020;21:E2621. [PMID: 32283813 DOI: 10.3390/ijms21072621] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang B, Zhou J, Wang F, Hu XW, Shi Y. Pyrazoline derivatives as tubulin polymerization inhibitors with one hit for Vascular Endothelial Growth Factor Receptor 2 inhibition. Bioorg Chem 2021;114:105134. [PMID: 34246970 DOI: 10.1016/j.bioorg.2021.105134] [Reference Citation Analysis]
2 Kumar A, Siwach K, Supuran CT, Sharma PK. A decade of tail-approach based design of selective as well as potent tumor associated carbonic anhydrase inhibitors. Bioorganic Chemistry 2022;126:105920. [DOI: 10.1016/j.bioorg.2022.105920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Al-Otaibi JS, Sheena Mary Y, Fazil S, Mary YS, Sarala S. Modeling the structure and reactivity landscapes of a pyrazole-ammonium ionic derivative using wavefunction-dependent characteristics and screening for potential anti-inflammatory activity. J Biomol Struct Dyn 2021;:1-13. [PMID: 34328395 DOI: 10.1080/07391102.2021.1957020] [Reference Citation Analysis]